CSIMarket
 

Medicure Inc   (MPH)

Medicure Inc 's

Competitiveness




 

MPH Sales vs. its Competitors Q4 2025



Comparing the current results to its competitors, Medicure Inc reported Revenue increase in the 4 quarter 2025 by 31.72 % year on year.
The sales growth was above Medicure Inc 's competitors' average revenue growth of 10.9 %, achieved in the same quarter.

List of MPH Competitors





Revenue Growth Comparisons




Net Income Comparison


Medicure Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 11.84 %

<<  MPH Stock Performance Comparisons


Medicure Inc 's Comment on Competition and Industry Peers


The Company’s Pharmacy Business Segment operates in a competitive environment that includes local, regional, and national pharmacy chains, independently owned pharmacies, supermarkets, mass merchandisers, and internet pharmacies. Competition from online retailers has increased significantly in recent years. Some competitors have merged with or acquired pharmaceutical services companies, pharmacy benefit managers (PBMs), health insurance companies, mail order facilities, or formed strategic partnerships with wholesalers or PBMs, potentially intensifying competition. The Company may face challenges competing effectively against these entities due to their greater financial and other resources. The profitability of the Company’s Marley Drug business depends on attracting and retaining loyal, repeat customers. Additionally, consolidation within the healthcare industry could negatively impact the Company’s business, financial condition, and results of operations. Competitors identified in filings include Gateway Pharmacy, Marley Drug, and West Olympia Pharmacy.



  

Overall company Market Share Q4 2025

Due to strong revenue growth of 31.72 % in Overall company Medicure Inc improved its market share, to approximately 0.01 %.


<<  More on MPH Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Medicure Inc




Biostax Corp
Share Performance



0.00%
This Year



Biostax Corp
Profile

Biostax Corp. acquires, develops, and commercializes pharmaceutical and biotechnology products.

More about Biostax Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.008 mill. $ - mill. $ -1.870 mill.


Os Therapies Incorporated
Share Performance



-1.22%
Over The Past 5 Days



Os Therapies Incorporated
Profile

OS Therapies develops treatments for osteosarcoma and other solid tumors.

More about Os Therapies Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 71.559 mill. $ - mill. $ -54.549 mill.


Contineum Therapeutics Inc
Share Performance



+59.36%
One Year



Contineum Therapeutics Inc
Profile

The company develops drug candidates focused on neuroscience, inflammation, and immunology diseases.

More about Contineum Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 629.536 mill. $ - mill. $ -58.444 mill.


Arrivent Biopharma inc
Share Performance



+56.29%
One Year



Arrivent Biopharma inc
Profile

The company develops and commercializes medicines for cancer treatment, with a focus on firmonertinib and other novel therapeutics.

More about Arrivent Biopharma inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,355.184 mill. $ - mill. $ -145.241 mill.


Structure Therapeutics Inc
Share Performance



-31.69%
This Year



Structure Therapeutics Inc
Profile

Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.

More about Structure Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10,113.265 mill. $ - mill. $ -170.337 mill.

159 more competitors available

Sign in to see all competitors

Sources: Medicure Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Medicure Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.